Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs71526081 | chr7:128717234 | AAT/A | 1.67E-5 | 134 | 42.27 | 31.17 | 17.1 | KM Plot |
| TGCT | rs7157618 | chr14:71010166 | C/T | 1.3E-5 | 134 | 38.2 | 66.9 | 21.43 | KM Plot |
| TGCT | rs71581958 | chr7:128665542 | C/T | 1.69E-5 | 134 | 42.27 | 30.3 | 17.1 | KM Plot |
| TGCT | rs71581969 | chr7:128722237 | C/A | 1.67E-5 | 134 | 42.27 | 31.17 | 17.1 | KM Plot |
| TGCT | rs71601701 | chr4:58371005 | G/C | 0 | 132 | 42.18 | 53.83 | 0.5 | KM Plot |
| TGCT | rs71611998 | chr4:47463698 | A/C | 0.000131 | 133 | 45.83 | 36.37 | 51.6 | KM Plot |
| TGCT | rs71629245 | chr3:172409691 | C/G | 0.000108 | 130 | 45.1 | 37.7 | 25.57 | KM Plot |
| TGCT | rs71765744 | chr6:42671817 | AAC/A | 4.45E-6 | 127 | 40.08 | 51.67 | 23.82 | KM Plot |
| TGCT | rs7195150 | chr16:82843203 | T/A | 5.14E-9 | 131 | 45.1 | 28.8 | 20.6 | KM Plot |
| TGCT | rs7202650 | chr16:27810548 | A/C | 1.15E-5 | 132 | 46.3 | 33.55 | 17.27 | KM Plot |
| TGCT | rs7219042 | chr17:39354740 | T/C | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs72237767 | chr2:221242849 | GAATC/G | 1.96E-5 | 134 | 45.47 | 16.82 | 94.85 | KM Plot |
| TGCT | rs723190 | chr12:6063974 | A/G | 6.52E-7 | 134 | 45.1 | 36.63 | 66.8 | KM Plot |
| TGCT | rs7246993 | chr19:37890154 | C/T | 1.37E-13 | 134 | 45.47 | 37.53 | 17.1 | KM Plot |
| TGCT | rs7252099 | chr19:37933780 | G/A | 1.76E-13 | 133 | 45.47 | 36.12 | 17.1 | KM Plot |